Defense Advanced Research Projects AgencyTagged Content List

Infectious Disease

Relating to ailments caused by pathogens

Showing 49 results for Disease RSS
04/13/2018
COL Matthew Hepburn joined DARPA as a program manager in 2013. He aims to address the dynamic threats of emerging infectious diseases with potential impact on national security.
04/13/2018
Dr. Eric Van Gieson joined DARPA as a Program Manager in August 2017 with the goal of using host-based methods to mitigate the impacts of emerging threats. He intends to explore epigenetic and real-time monitoring approaches that can dynamically guide healthcare decisions and therapy as well as new methods of increasing patient survival in austere environments using intelligent systems partnered with local care providers.
04/13/2018
Dr. Renee Wegrzyn joined DARPA as a Program Manager in 2016 and is interested in applying the tools of synthetic biology to support biosecurity and outpace infectious disease. She manages the Living Foundries program which seeks to transform biology into an engineering practice by developing the tools, technologies, methodologies, and infrastructure to prototype and scale engineered microbes that can produce molecules that are of value for government and commercial use.
04/13/2018
Dr. Tristan McClure-Begley joined DARPA as a Program Manager in October 2017. He came to DARPA from the University of Colorado, Boulder, where he was a Research Assistant Professor in the Department of Molecular, Cellular and Developmental Biology. His academic studies focused on molecular mechanisms of perturbations to complex biological systems, particularly drugs of abuse, toxins and neurodevelopmental disorders.
DARPA’s Biological Technologies Office develops capabilities that embrace the unique properties of biology—adaptation, replication, complexity—and use these features to revolutionize how the United States prepares and protects its citizens, Soldiers, Sailors, Airmen, and Marines from threats at home and abroad. Example new Department of Defense capabilities include the ability to counter novel bioterrorism, deploy innovative biological countermeasures to protect its forces, and accelerate warfighter readiness/overmatch for adversary threats.